You are here

  • Home
  • Archive
  • Volume 19, Issue 2
  • TCH034 Proteomic approach to investigating the molecular integrity of infliximab after reconstitution and dilution in typical hospital conditions

Article metrics

Article menu
Download PDFPDF
Abstracts
Presentations on Thursday, March 22nd, 8:30 - 10:00, Amber 11
TCH034 Proteomic approach to investigating the molecular integrity of infliximab after reconstitution and dilution in typical hospital conditions

 

Online download statistics by month:

Online download statistics by month: March 2012 to March 2024

AbstractFullPdf
Mar 20121602
Apr 2012500
May 2012512
Jun 2012701
Jul 2012201
Aug 2012300
Sep 2012900
Oct 20121201
Nov 2012400
Dec 2012501
Jan 2013201
Feb 2013300
Mar 2013600
Apr 2013400
May 2013400
Jun 2013100
Aug 2013100
Sep 2013200
Oct 2013200
Nov 2013400
Dec 2013500
Jun 2014300
Jul 2014500
Aug 2014400
Sep 2014100
Oct 2014300
Nov 2014600
Dec 2014700
Jan 2015200
Feb 2015200
Mar 2015100
Apr 2015500
Jul 2015200
Sep 2015100
Nov 2015600
Mar 2016100
May 2016200
Jun 2016800
Jul 2016300
Aug 2016200
Sep 2016801
Oct 2016300
Nov 2016300
Dec 2016400
Jan 2017700
Feb 2017200
Mar 2017500
Apr 2017300
May 2017200
Jul 2017200
Aug 2017400
Sep 2017600
Oct 2017400
Nov 20171000
Dec 20171200
Jan 2018400
Feb 2018400
Mar 20181800
Apr 20181600
May 20185400
Jun 20184200
Jul 2018800
Aug 2018800
Sep 20181200
Nov 2018200
Dec 2018800
Jan 2019800
Feb 2019800
Mar 2019400
Apr 2019700
May 2019400
Jun 2019200
Aug 2019200
Sep 2019400
Nov 2019800
Dec 2019200
Jan 2020400
Feb 2020400
Mar 2020200
Jul 2020800
Aug 2020400
Sep 2020900
Oct 20206400
Nov 20206000
Dec 2020400
Jan 2021800
Feb 2021400
Apr 2021400
Nov 20211000
Dec 2021800
Jan 2022200
Feb 2022600
Mar 2022800
Apr 2022200
Jun 20221400
Jul 2022400
Aug 2022200
Sep 2022200
Oct 2022200
Nov 2022800
Dec 20221400
Mar 2023400
May 2023400
Jul 20231000
Aug 2023600
Sep 2023600
Nov 2023400
Dec 2023200
Mar 2024400
Total763110